C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/18 (2006.01) A61K 38/18 (2006.01) A61K 38/24 (2006.01) C07K 14/505 (2006.01) C07K 14/59 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/62 (2006.01) A61K 38/00 (2006.01)
Patent
CA 2147124
Erythropoietin analogs having at least one additional site for glycosylation, or a rearrangement of at least one site for glycosylation are disclosed. The invention also relates to DNA sequences encoding said erythropoietin analogs, and recombinant plasmids and host cells for analog expression.
L'invention concerne des analogues d'érythropoïétine possédant au moins un site additionnel de glycosylation ou une redisposition d'au moins un site de glycosylation. Elle concerne également des séquences d'ADN codant lesdits analogues d'érythropoïétine, ainsi que des plasmides recombinés et des cellules hôtes d'expression d'analogues.
Byrne Thomas E.
Elliott Steven G.
Amgen Inc.
Kirin-Amgen Inc.
Ridout & Maybee Llp
LandOfFree
Erythropoietin analogs does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Erythropoietin analogs, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythropoietin analogs will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1661266